Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature.

Abstract

Although the relationship between antipsychotic medication, particularly second-generation antipsychotics (SGAs), and metabolic disturbance is increasingly accepted, there is an important, but little recognised, potential interaction between this and the other important serious adverse effect of neuroleptic malignant syndrome (NMS). We report a case of a 35… (More)
DOI: 10.1177/0269881108096901

Topics

  • Presentations referencing similar topics